CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Sac-TMT Combo Meets PFS End Point in PD-L1–Negative NSCLC Trial]]>

Phase 3pembrolizumab

Read the original article

Published by Cancer Network on July 15, 2026 4:00 PM

Read Original